95 related articles for article (PubMed ID: 31099000)
21. Lentivirus-mediated antagomir expression.
Surdziel E; Eder M; Scherr M
Methods Mol Biol; 2010; 667():237-48. PubMed ID: 20827538
[TBL] [Abstract][Full Text] [Related]
22. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
23. Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
D'Abundo L; Callegari E; Bresin A; Chillemi A; Elamin BK; Guerriero P; Huang X; Saccenti E; Hussein EMAA; Casciano F; Secchiero P; Zauli G; Calin GA; Russo G; Lee LJ; Croce CM; Marcucci G; Sabbioni S; Malavasi F; Negrini M
Oncogene; 2017 Nov; 36(47):6617-6626. PubMed ID: 28783166
[TBL] [Abstract][Full Text] [Related]
24. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts.
Liu J; Dang L; Li D; Liang C; He X; Wu H; Qian A; Yang Z; Au DW; Chiang MW; Zhang BT; Han Q; Yue KK; Zhang H; Lv C; Pan X; Xu J; Bian Z; Shang P; Tan W; Liang Z; Guo B; Lu A; Zhang G
Biomaterials; 2015 Jun; 52():148-60. PubMed ID: 25818421
[TBL] [Abstract][Full Text] [Related]
25. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P
Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539
[TBL] [Abstract][Full Text] [Related]
26. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
27. Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.
Saenz-Pipaon G; Dichek DA
Atherosclerosis; 2023 Jun; 374():44-54. PubMed ID: 36577600
[TBL] [Abstract][Full Text] [Related]
28. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
[TBL] [Abstract][Full Text] [Related]
29. In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge.
Kent OA; Steenbergen C; Das S
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985373
[TBL] [Abstract][Full Text] [Related]
30. miRNAs in normal and malignant B cells.
Kotani A; Harnprasopwat R; Toyoshima T; Kawamata T; Tojo A
Int J Hematol; 2010 Sep; 92(2):255-61. PubMed ID: 20614203
[TBL] [Abstract][Full Text] [Related]
31. Induction of differentiation-specific miRNAs in TPA-induced myeloid leukemia cells through MEK/ERK activation.
Wang J; Liu L; Xie L; Xiang G; Zhou Y
Int J Mol Med; 2013 Jan; 31(1):59-66. PubMed ID: 23175175
[TBL] [Abstract][Full Text] [Related]
32. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models.
Murdaca G; Tonacci A; Negrini S; Greco M; Borro M; Puppo F; Gangemi S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412612
[TBL] [Abstract][Full Text] [Related]
33. miR-139-5p controls translation in myeloid leukemia through EIF4G2.
Emmrich S; Engeland F; El-Khatib M; Henke K; Obulkasim A; Schöning J; Katsman-Kuipers JE; Michel Zwaan C; Pich A; Stary J; Baruchel A; de Haas V; Reinhardt D; Fornerod M; van den Heuvel-Eibrink MM; Klusmann JH
Oncogene; 2016 Apr; 35(14):1822-31. PubMed ID: 26165837
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
35. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
36. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-15a/16-1 Antagomir Ameliorates Ischemic Brain Injury in Experimental Stroke.
Yang X; Tang X; Sun P; Shi Y; Liu K; Hassan SH; Stetler RA; Chen J; Yin KJ
Stroke; 2017 Jul; 48(7):1941-1947. PubMed ID: 28546328
[TBL] [Abstract][Full Text] [Related]
38. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
39. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
Deng R; Shen N; Yang Y; Yu H; Xu S; Yang YW; Liu S; Meguellati K; Yan F
Biomaterials; 2018 Jun; 167():80-90. PubMed ID: 29554483
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
